infections, and does not develop renal impairment are also important nursing responsibilities; however, they do not help to significantly reduce the risk for cytotoxicity and tumor lysis syndrome. Question 6 1 out of 1 points A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin therapy? Response Feedback : Oprelvekin stimulates the formation of platelets, so the nurse should regularly monitor the platelet count to determine the duration of the therapy. The therapy should be continued until the postnadir platelet count is at least 50,000 cells/mm 3 . The oprelvekin therapy is effective if the platelet count rises to a normal range without severe bleeding. Fluid retention, weight gain, and arrhythmias are major adverse effects of oprelvekin therapy and would not be a measure of the efficacy and duration of the therapy. Question 7 1 out of 1 points A nurse is to use a single-dose 1 mL vial to administer 0.5 mL of epoetin alfa to a 39-year-old woman who is being treated for chemotherapy- induced anemia. Which of the following will the nurse do with the unused portion of the drug? Response Feedback : The single-dose 1-mL vial does not have preservatives. In order to prevent contamination, the nurse will discard the unused portion of the drug. A 2-mL vial does have preservatives and
would be stored at 2°C to 8°C to be used again. The 2-mL vial should be discarded 21 days after initial entry to prevent use of a possibly contaminated product. Question 8 1 out of 1 points A nurse educator who coordinates the staff education on an oncology unit is conducting an inservice on targeted therapies. What potential benefit of targeted therapies should the nurse highlight in this education session? Response Feedback : By focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than current treatments and less harmful to normal cells so that they may produce fewer adverse effects. However, adverse effects are not wholly absent. These drugs are not normally used as cancer prophylaxis and many are prohibitively expensive. Question 9 1 out of 1 points An older adult woman has been diagnosed with acute lymphoblastic leukemia (ALL) and her care team has identified potential benefits of imatinib. Which of the following characteristics of this patient's current health status may preclude the use of imatinib? Response Feedback : Imatinib may be associated with edema. Patients should be weighed regularly and assessed for signs of fluid retention that could be severe. The risk of edema increases with higher doses of imatinib and age greater than 65 years. Previous strokes, orthopedic surgery, or well-controlled diabetes may not contraindicate the use of imatinib.
- Summer '15
- adverse effects, Chemotherapy, Leukemia, Rituximab, epoetin alfa